Compare ASB & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ASB | INSP |
|---|---|---|
| Founded | 1861 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.5B | 3.8B |
| IPO Year | N/A | 2018 |
| Metric | ASB | INSP |
|---|---|---|
| Price | $25.74 | $91.83 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 17 |
| Target Price | $28.00 | ★ $137.63 |
| AVG Volume (30 Days) | ★ 2.1M | 2.0M |
| Earning Date | 01-22-2026 | 02-09-2026 |
| Dividend Yield | ★ 3.70% | N/A |
| EPS Growth | N/A | ★ 34.77 |
| EPS | 0.98 | ★ 1.48 |
| Revenue | ★ $1,097,713,000.00 | $882,622,000.00 |
| Revenue This Year | $57.84 | $15.00 |
| Revenue Next Year | $9.24 | $11.24 |
| P/E Ratio | ★ $26.43 | $62.71 |
| Revenue Growth | 8.93 | ★ 16.81 |
| 52 Week Low | $18.32 | $70.77 |
| 52 Week High | $27.58 | $216.01 |
| Indicator | ASB | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 43.45 | 35.55 |
| Support Level | $26.28 | $93.05 |
| Resistance Level | $26.72 | $97.00 |
| Average True Range (ATR) | 0.42 | 6.23 |
| MACD | -0.13 | -4.21 |
| Stochastic Oscillator | 1.63 | 3.00 |
Associated Banc-Corp is a bank holding company. The company through its subsidiaries provides a broad array of banking and nonbanking products and services to individuals and businesses. The company operates in three reportable segments; Corporate and Commercial Specialty; Community, Consumer, and Business; and Risk Management and Shared Services. The majority of its revenue is derived from the Corporate and Commercial Specialty and Community, Consumer, and Business segments.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.